Warren S L
Ann Allergy. 1980 Jul;45(1):37-42.
The discovery and subsequent development of interferon as an anti-viral, ant-cancer therapeutic agent may well be a major milestone in the history of medical therapeutics. The results of the limited clinical trials available offer great promise for this biological agent. Only time, with large scale clinical trials, will serve to evaluate the true benefit of this modality of therapy. In the interim it is most desirable that the prcticing allergist-immunologist maintain an awareness of the use and mens of production of interferon so that he has available at his descretion a therapeutic modality for possible use in cases that have drastic, very poor or no therapeutic alternatives, remembering that each case add to the compendium of clinical knowledge.
干扰素作为一种抗病毒、抗癌治疗药物的发现及后续研发很可能是医学治疗史上的一个重要里程碑。现有的有限临床试验结果为这种生物制剂带来了很大希望。只有通过大规模临床试验，假以时日，才能评估这种治疗方式的真正益处。在此期间，非常希望执业过敏症专科医生和免疫学家了解干扰素的用途及生产方法，以便在遇到治疗方案极端有限、非常糟糕或根本没有治疗方案的病例时，能够自行决定使用这种治疗方式，要记住每个病例都会丰富临床知识汇编。
